Lisdexamfetamine for methamphetamine withdrawal (OLAM trial) Oral Lisdexamfetamine for the treatment of Acute Methamphetamine withdrawal (the OLAM trial): A randomised controlled trial
Ketamine-assisted psychotherapy for methamphetamine use disorder (KAPPA) An open-label, safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder
Methamphetamine treatment: new and upcoming options An update on new and upcoming treatment options for clinicians, researchers and people who use methamphetamine.
GHB Insights for service providers The effects of GHB, its use in Australia, and harm reduction & treatment principles.
Methamphetamine: working with family and friends How can we incorporate family and friends into treatment, and support them in their own right?
